meta_pixel
Tapesearch Logo
Log in
KQED's Forum

As Coronavirus Cases Spike, Vaccine News Offers Hope

KQED's Forum

KQED

News, News Commentary, Politics

4.2727 Ratings

🗓️ 17 November 2020

⏱️ 21 minutes

🧾️ Download transcript

Summary

Biotechnology company Moderna announced Monday that its coronavirus vaccine candidate appears to be 94.5% effective against the disease. The news comes one week after Pfizer announced that its vaccine was more than 90% effective in a clinical trial. As California rolls back reopening plans amid a spike in cases, we’ll discuss next steps for the new vaccines and what we know about safety and long-term effectiveness. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

Support for KQED podcasts comes from San Francisco International Airport. Did you know that

0:05.7

SFO has a world-class museum? Get ready to be wowed by art, history, science, and cultural exhibitions

0:12.3

throughout the terminals. Learn more at flysfo.com slash museum. Greetings boomtown. The Xfinity

0:20.6

Wi-Fi is booming.

0:22.4

Xfinity combines the power of internet and mobile.

0:25.5

So we've all got lightning fast speeds at home and on the go.

0:29.1

Learn more at Xfinity.com.

0:31.0

Restrictions apply.

0:31.7

Xfinity internet required.

0:32.8

Actual speeds vary.

0:34.8

From KQED.

0:37.2

Welcome back to Forum. I'm Michael Krasassney biotechnology company moderna announced yesterday that

0:43.2

its coronavirus vaccine candidate appears to be 94.5 percent effective against the disease the news comes

0:50.5

one week after Pfizer announced that its vaccine was more than 90% effective in a clinical trial.

0:56.3

And as California rolls back reopening plans amid a spike in cases,

0:59.7

we're going to discuss next steps for the new vaccines and what we know about safety and long-term effectiveness.

1:05.8

What vaccine questions do you have?

1:07.8

You can give us a call right now at 866-733-6786. Again, that's 866-733-6786. You can also, of course, get in touch on Twitter and Facebook. We're at KQED Forum or email any questions you may have to forum at kQED.org. And joining us is Damien Gardi, National Biotech reporter for Stapp.

1:27.7

Welcome to the program.

1:29.7

Hi, Michael.

1:30.2

Thanks for having me.

1:31.0

Glad to have you.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from KQED, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of KQED and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.